Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker
Open Access
- 31 March 2010
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (9) , 2518-2525
- https://doi.org/10.1245/s10434-010-1038-8
Abstract
Biomarkers for accurate diagnosis of early hepatocellular carcinoma (HCC) are limited in number and clinical validation. We applied SELDI-TOF-MS ProteinChiKeywords
This publication has 34 references indexed in Scilit:
- Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parametersBMC Cancer, 2009
- Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinomaProteomics, 2008
- Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver DiseaseClinical Cancer Research, 2008
- Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approachProteome Science, 2008
- Artificial neural networks and decision tree model analysis of liver cancer proteomesBiochemical and Biophysical Research Communications, 2007
- Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classificationZeitschrift für Krebsforschung und Klinische Onkologie, 2007
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseasesHepatology, 2004
- Artificial Neural Networks Analysis of Surface-Enhanced Laser Desorption/Ionization Mass Spectra of Serum Protein Pattern Distinguishes Colorectal Cancer from Healthy PopulationClinical Cancer Research, 2004
- Applicability of Intraoperative Parathyroid Hormone Assay During ThyroidectomyAnnals of Surgery, 2002